Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Flow Cytometry × Myeloid × Clear all

Status

Completed 14 Terminated 3 Unknown 2 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Lymphoma 1 Lymphohistiocytosis, Hemophagocytic 1

Interventions

fludarabine 32 Cyclophosphamide 27 venetoclax 25 Azacitidine 24 Specimen Handling 23 Biopsy 20 Cytarabine 16 fludarabine phosphate 15 ruxolitinib 13 Whole-Body Irradiation 13 Melphalan 12 Stem Cell Transplantation 11 Injections 11 Decitabine 11 Busulfan 11 Tacrolimus 10 Mycophenolic Acid 8 asciminib 7 Thiotepa 7 Methotrexate 7 Granulocyte Colony-Stimulating Factor 7 decitabine and cedazuridine drug combination 6 Magnetic Resonance Spectroscopy 6 Idarubicin 6 Hematopoietic Stem Cell Transplantation 6 nilotinib 5 X-Rays 5 Filgrastim 5 Daunorubicin 5 Dasatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06585124 2024-09-05

LA-HLH

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

LymphoidMyeloid

Lymphoma, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡